Control of influenza virus infection by immunity to conserved viral features. (Q30343902)

20 June 2017

1 reference

title

Control of influenza virus infection by immunity to conserved viral features. (English)

1 reference

20 June 2017

Suzanne L Epstein

1

1 reference

20 June 2017

publication date

1 December 2003

1 reference

Expert Review of Anti-infective Therapy

20 June 2017

published in

1 reference

20 June 2017

volume

1

1 reference

20 June 2017

issue

4

1 reference

20 June 2017

page(s)

627-638

1 reference

The importance of animal influenza for human disease.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Characterization of a human H9N2 influenza virus isolated in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Intracellular neutralization of virus by immunoglobulin A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Cytotoxic T-cell immunity to influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Declining T-cell immunity to influenza, 1977-82

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.4.627

21 January 2018

Identifiers

DOI

10.1586/14787210.1.4.627

1 reference

20 June 2017

1 reference